438 related articles for article (PubMed ID: 22629545)
21. [18F-FDG PET/CT for the detection of primary tumors metastasizing to lymph nodes of the neck].
Hu YY; Liang PY; Lin XP; Zhang X; Zhang WG; Fan W
Ai Zheng; 2009 Mar; 28(3):312-7. PubMed ID: 19619449
[TBL] [Abstract][Full Text] [Related]
22. 18F-FDG-PET/CT is of limited value in primary staging of early stage cervical cancer.
Driscoll DO; Halpenny D; Johnston C; Sheehy N; Keogan M
Abdom Imaging; 2015 Jan; 40(1):127-33. PubMed ID: 25015401
[TBL] [Abstract][Full Text] [Related]
23. Utility of combined (18)F-fluorodeoxyglucose-positron emission tomography and computed tomography in patients with cervical metastases from unknown primary tumors.
Roh JL; Kim JS; Lee JH; Cho KJ; Choi SH; Nam SY; Kim SY
Oral Oncol; 2009 Mar; 45(3):218-24. PubMed ID: 18804404
[TBL] [Abstract][Full Text] [Related]
24. Impact of [18F]-2-fluorodeoxyglucose-positron emission tomography/computed tomography on previously untreated head and neck cancer patients.
Fleming AJ; Smith SP; Paul CM; Hall NC; Daly BT; Agrawal A; Schuller DE
Laryngoscope; 2007 Jul; 117(7):1173-9. PubMed ID: 17603315
[TBL] [Abstract][Full Text] [Related]
25.
Abadi P; Johansen A; Godballe C; Gerke O; Høilund-Carlsen PF; Thomassen A
Ann Nucl Med; 2017 Feb; 31(2):101-108. PubMed ID: 27921286
[TBL] [Abstract][Full Text] [Related]
26. Hybrid imaging for detection of carcinoma of unknown primary: A preliminary comparison trial of whole-body PET/MRI versus PET/CT.
Ruhlmann V; Ruhlmann M; Bellendorf A; Grueneisen J; Sawicki LM; Grafe H; Forsting M; Bockisch A; Umutlu L
Eur J Radiol; 2016 Nov; 85(11):1941-1947. PubMed ID: 27776644
[TBL] [Abstract][Full Text] [Related]
27. Impact of 3T multiparametric MRI and FDG-PET-CT in the evaluation of occult primary cancer with cervical node metastasis.
Gődény M; Lengyel Z; Polony G; Nagy ZT; Léránt G; Zámbó O; Remenár É; Tamás L; Kásler M
Cancer Imaging; 2016 Nov; 16(1):38. PubMed ID: 27814768
[TBL] [Abstract][Full Text] [Related]
28. Detection of occult primary tumors in patients with cervical metastases of unknown primary tumors: comparison of (18)F FDG PET/CT with contrast-enhanced CT or CT/MR imaging-prospective study.
Lee JR; Kim JS; Roh JL; Lee JH; Baek JH; Cho KJ; Choi SH; Nam SY; Kim SY
Radiology; 2015 Mar; 274(3):764-71. PubMed ID: 25405771
[TBL] [Abstract][Full Text] [Related]
29. Diagnostic evaluation of squamous cell carcinoma metastatic to cervical lymph nodes from an unknown head and neck primary site.
Cianchetti M; Mancuso AA; Amdur RJ; Werning JW; Kirwan J; Morris CG; Mendenhall WM
Laryngoscope; 2009 Dec; 119(12):2348-54. PubMed ID: 19718744
[TBL] [Abstract][Full Text] [Related]
30. Role of 18-Fludeoxyglucose positron emission tomography-computed tomography and subsequent panendoscopy in head and neck squamous cell carcinoma of unknown primary.
Mani N; George MM; Nash L; Anwar B; Homer JJ
Laryngoscope; 2016 Jun; 126(6):1354-8. PubMed ID: 26671043
[TBL] [Abstract][Full Text] [Related]
31. Screening for distant metastases before salvage surgery in patients with recurrent head and neck squamous cell carcinoma: a retrospective case series comparing thoraco-abdominal CT, positron emission tomography and abdominal ultrasound.
Fakhry N; Michel J; Colavolpe C; Varoquaux A; Dessi P; Giovanni A
Clin Otolaryngol; 2012 Jun; 37(3):197-206. PubMed ID: 22520870
[TBL] [Abstract][Full Text] [Related]
32. Scanning with 18F-FDG-PET/CT for detection of pelvic nodal involvement in inguinal node-positive penile carcinoma.
Graafland NM; Leijte JA; Valdés Olmos RA; Hoefnagel CA; Teertstra HJ; Horenblas S
Eur Urol; 2009 Aug; 56(2):339-45. PubMed ID: 19477581
[TBL] [Abstract][Full Text] [Related]
33. The added value of 18F-fluorodeoxyglucose positron emission tomography computed tomography in patients with neck lymph node metastases from an unknown primary malignancy.
Prowse SJ; Shaw R; Ganeshan D; Prowse PM; Hanlon R; Lewis-Jones H; Wieshmann H
J Laryngol Otol; 2013 Aug; 127(8):780-7. PubMed ID: 23919968
[TBL] [Abstract][Full Text] [Related]
34. Lymph node metastasis of squamous cell carcinoma from an unknown primary in the upper and middle neck: Impact of (18)F-fluorodeoxyglucose positron emission tomography/computed tomography.
Deron PB; Bonte KM; Vermeersch HF; Van de Wiele C
Cancer Biother Radiopharm; 2011 Jun; 26(3):331-4. PubMed ID: 21711095
[TBL] [Abstract][Full Text] [Related]
35. [18F]fluoromethylcholine (FCH) positron emission tomography/computed tomography (PET/CT) for lymph node staging of prostate cancer: a prospective study of 210 patients.
Poulsen MH; Bouchelouche K; Høilund-Carlsen PF; Petersen H; Gerke O; Steffansen SI; Marcussen N; Svolgaard N; Vach W; Geertsen U; Walter S
BJU Int; 2012 Dec; 110(11):1666-71. PubMed ID: 22520686
[TBL] [Abstract][Full Text] [Related]
36. Cervical lymph node metastases of squamous cell carcinoma of unknown origin: the diagnostic value of FDG PET/CT and clinical outcome.
Dale E; Moan JM; Osnes TA; Bogsrud TV
Eur Arch Otorhinolaryngol; 2017 Feb; 274(2):1015-1019. PubMed ID: 27671150
[TBL] [Abstract][Full Text] [Related]
37. The role of (18)F-FDG PET/CT in the diagnosis of breast cancer and lymph nodes metastases and micrometastases may be limited.
Zhang X; Wu F; Han P
Hell J Nucl Med; 2014; 17(3):177-83. PubMed ID: 25526754
[TBL] [Abstract][Full Text] [Related]
38. Utility of ¹⁸F-FDG PET/CT in identifying penile squamous cell carcinoma metastatic lymph nodes.
Rosevear HM; Williams H; Collins M; Lightfoot AJ; Coleman T; Brown JA
Urol Oncol; 2012 Sep; 30(5):723-6. PubMed ID: 21396850
[TBL] [Abstract][Full Text] [Related]
39. Cervical lymph node metastases of unknown origin: primary tumor detection with whole-body positron emission tomography/computed tomography.
Nassenstein K; Veit-Haibach P; Stergar H; Gutzeit A; Freudenberg L; Kuehl H; Fischer M; Barkhausen J; Bockisch A; Antoch G
Acta Radiol; 2007 Dec; 48(10):1101-8. PubMed ID: 17963088
[TBL] [Abstract][Full Text] [Related]
40. Diagnostic work-up and outcome of cervical metastases from an unknown primary.
Guntinas-Lichius O; Peter Klussmann J; Dinh S; Dinh M; Schmidt M; Semrau R; Mueller RP
Acta Otolaryngol; 2006 May; 126(5):536-44. PubMed ID: 16698706
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]